Andere talen Stoke Therapeutics, Inc.

Aandelen

Vertraagde tijd Nasdaq Andere beurzen 21:46:33 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
12,07 ^USD	+3,25%		+0,17%	+129,47%

17/04	Stoke Therapeutics benoemt Jason Hoitt tot Chief Commercial Officer	CI
28/03	Sectorupdate: Gezondheidszorgaandelen stijgen donderdag premarket	MT

Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer	17/04
Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer	17/04
Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference	04/04
Sector Update: Health Care Stocks Advance Premarket Thursday	28/03
Stoke Therapeutics Prices Upsized $125 Million Share Offering	28/03
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering	28/03
North American Morning Briefing : Stocks Edge -2-	27/03
Stoke Therapeutics Plans $75 Million Public Offering	26/03
MÄRKTE USA/Etwas leichter - Zurückhaltung vor Inflationsdaten	26/03
Stoke Therapeutics Announces Proposed Public Offering	26/03
Sector Update: Health Care Stocks Advance Late Afternoon	26/03
Stoke Therapeutics Rises After Investigational Drug Shows Improvement in Dravet Syndrome Patients	26/03
Top Midday Gainers	26/03
MÄRKTE USA/Gut behauptet - Hoffen auf Inflationsdaten	26/03
Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading	26/03
US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings	26/03
Top Premarket Gainers	26/03
MÄRKTE USA/Etwas fester - Hoffen auf Preisdaten	26/03
North American Morning Briefing : Markets Steady as Traders Eye Next Inflation Gauge	26/03
Stoke Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03

Geen resultaten voor deze zoekopdracht